Oral & Maxillofacial Surgeon is categorized under Oral Pathologist in Pittsburgh, PA and active since 1988.
Oral & Maxillofacial Surgeon was established in 1988, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Oral Pathologist business, which does work in the B2C market, and is classified as a Oral Pathologist, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact John M Pierce at the company’s single location by writing to 580 South Aiken Avenue # 630, Pittsburgh, Pennsylvania PA 15232 or by phoning (412) 687-5589. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Oral & Maxillofacial Surgeon |
| Contact Person: | John M Pierce |
| Address: | 580 South Aiken Avenue # 630, Pittsburgh, Pennsylvania 15232 |
| Phone Number: | (412) 687-5589 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1988 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Oral Pathologist |
| SIC Code: | 8021 |
| NAICS Code: | 6211110 |
| Share This Business: |
Oral & Maxillofacial Surgeon was started in 1988 to provide professional Oral Pathologist under the SIC code 8021 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact John M Pierce for inquiries that concern Oral & Maxillofacial Surgeon by calling the company number (412) 687-5589, as your correspondence is most welcome. Additionally, the physical location of the single location of Oral & Maxillofacial Surgeon can be found at the coordinates 40.45353,-79.93725 as well as the street address 580 South Aiken Avenue # 630 in Pittsburgh, Pennsylvania 15232.
For its online presence, you may visit Oral & Maxillofacial Surgeon’s website at and engage with its social media outlets through on Twitter and on Facebook.